Publikationen in Zusammenarbeit mit Forschern von Hospital Universitario 12 de Octubre (192)

2016

  1. Continuation of the ESH-CHL-SHOT trial after publication of the SPRINT: Rationale for further study on blood pressure targets of antihypertensive treatment after stroke

    Journal of Hypertension, Vol. 34, Núm. 3, pp. 393-396

2014

  1. Blood pressure and LDL-cholesterol targets for prevention of recurrent strokes and cognitive decline in the hypertensive patient: Design of the European Society of Hypertension-Chinese Hypertension League Stroke in Hypertension Optimal Treatment randomized trial

    Journal of Hypertension, Vol. 32, Núm. 9, pp. 1888-1897

  2. Blood pressure and low-density lipoprotein-cholesterol lowering for prevention of strokes and cognitive decline: A review of available trial evidence

    Journal of Hypertension, Vol. 32, Núm. 9, pp. 1741-1750

2009

  1. Reappraisal of European guidelines on hypertension management: A European Society of Hypertension Task Force documental

    Blood Pressure, Vol. 18, Núm. 6, pp. 308-347

2007

  1. Efficacy and tolerability of olmesartan medoxomil in patients with mild to moderate essential hypertension: The OLMEBEST study

    Clinical Drug Investigation, Vol. 27, Núm. 8, pp. 545-558

  2. Evolution of blood pressure control in Spain [2]

    Journal of Hypertension

2005

  1. Do we need to target 'prediabetic' hypertensive patients?

    Journal of Hypertension, Vol. 23, Núm. 12, pp. 2119-2125

  2. High blood pressure, alcohol and cardiovascular risk

    Journal of Hypertension, Vol. 23, Núm. 1, pp. 226-229

  3. High blood pressure, smoking and cardiovascular risk

    Journal of Hypertension, Vol. 23, Núm. 1, pp. 219-221

  4. Treatment of hypertension in dialysed patients

    Journal of Hypertension, Vol. 23, Núm. 1, pp. 222-226

2004

  1. Calcium channel blockade and preservation of renal graft function in cyclosporine-treated recipients: A prospective randomized placebo-controlled 2-year study

    Transplantation, Vol. 78, Núm. 8, pp. 1204-1211

  2. Development of chronic kidney disease and cardiovascular prognosis in essential hypertensive patients

    Journal of the American Society of Nephrology, Vol. 15, Núm. 6, pp. 1616-1622

  3. FOROSTAT 2003: Multidisciplinary forum on statins. Proceedings of the 2nd FOROSTAT, Rome, October 2003 - Foreword

    Drugs

  4. Hypertensive Renal Damage in Metabolic Syndrome Is Associated with Glucose Metabolism Disturbances

    Journal of the American Society of Nephrology

  5. Microalbuminuria

    Clinical and Experimental Hypertension

  6. Olmesartan medoxomil: New signs in hypertension - Introduction

    Clinical Therapeutics

  7. Pros y contras de la inhibición del sistema renina angiotensina

    Nefrologia, Vol. 24, Núm. SUPPL.1, pp. 69-70

  8. The KARTAN study: A postmarketing assessment of lrbesartan in patients with hypertension

    Clinical Therapeutics, Vol. 26, Núm. 2, pp. 232-244

2003

  1. Combination is better than monotherapy with ACE inhibitor or angiotensin receptor antagonist at recommended doses

    JRAAS - Journal of the Renin-Angiotensin-Aldosterone System, Vol. 4, Núm. 1, pp. 43-47

  2. Double (dual) renal transplants for elderly recipients, using elderly cadaveric donors

    Dialysis and Transplantation, Vol. 32, Núm. 8, pp. 499-503+513